Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Psychosocial Care (behavioral) — also listed as: First Follow-Up, Second Follow-up, Third Follow-up, Fourth Follow-up, Fifth Follow-up, Sixth Follow-up, Seventh Follow-up

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• İstanbul University-Cerrrahpaşa
  Istanbul, Turkey (Türkiye)
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Triptorelin acetate (a-GnRH) (drug) — also listed as: Decapeptyl 0.1 mg®
• Ovitrelle® (hCG) (drug)
• Decapeptyl 0.1 mg® (a-GnRH) and Ovitrelle® (hCG) used together (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Instituto Bernabeu
  Palma de Mallorca, Mallorca, Spain
  Site recruitment: Recruiting
• Instituto Bernabeu
  Albacete, Spain
  Site recruitment: Recruiting
• Instituto Bernabeu
  Alicante, Spain
  Site recruitment: Recruiting
• Instituto Bernabeu
  Madrid, Spain
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Physician phone call (behavioral)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Boston IVF
  Waltham, Massachusetts, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Dual trigger (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• IVI RMA Abu Dhabi
  Abu Dhabi, United Arab Emirates
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Enoxaparin (drug) — also listed as: Heparin, Low molecular weight heparin

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Abdurahman Khalil
  Boston, Massachusetts, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• hCG (drug)
• Saline Solution (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Ayman Shehata Dawood
  Tanta, Algharbia, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• hCG (drug) — also listed as: human chorionic gonadotropin
• Ultrasound (diagnostic_test) — also listed as: transvaginal scan
• Blood test (other) — also listed as: Progesterone, Luteinizing Hormone, Estradiol

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• ART Fertility Clinics LLC
  Abu Dhabi, United Arab Emirates
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Duphaston (drug)
• Gonadotropin (drug) — also listed as: Fostimon, Menopure, Menogon, Gonapure
• Cetrotide Injectable Product (drug)
• Decapeptyl (drug)
• Chorionic Gonadotropin (drug) — also listed as: choriomon
• Combined Oral Contraceptive (drug) — also listed as: Gynera
• Cyclo-Progynova (drug)
• progesterone (drug) — also listed as: prontogest

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Elshatby University Maternity Hospital
  Alexandria, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Heparin (drug) — also listed as: cal-heparin 5000 U, juspirin

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Benha univesity hospital
  Banhā, El Qualyobia, Egypt
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Methotrexate (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Nishtar Medical University Hospital
  Multan Khurd, Pu, Pakistan
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Follitropin beta (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Follitropin beta (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• ganirelix (drug) — also listed as: Orgalutran®, Org 37462
• triptorelin (drug) — also listed as: Decapeptyl

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Corifollitropin alfa (drug) — also listed as: SCH 900962, MK-8962
• recFSH (follitropin beta) (biological) — also listed as: follitropin beta, Puregon®, Follistim®
• gonadatropin releasing hormone (GnRH) antagonist ganirelix (drug)
• human chorion gonadotropin (hCG) (biological)
• progesterone (biological)
• placebo-recFSH (follitropin beta) (drug)
• placebo-corifollitropin alfa (drug)
• open-label recFSH (follitropin beta) (biological)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• SCH 900962 / Corifollitropin alfa / Org 36286 (biological) — also listed as: MK-8962
• RecFSH / follitropin beta (biological) — also listed as: Follistim® AQ Cartridge
• Placebo for SCH 900962 (drug)
• Placebo for recFSH (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• corifollitropin alfa (drug) — also listed as: Elonva

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• corifollitropin alfa (drug) — also listed as: Org 36286
• recFSH (follitropin alfa) (biological) — also listed as: Puregon®/Follistim®
• gonadatropin releasing hormone (GnRH) antagonist ganirelix (drug)
• human chorion gonadatropin (hCG) (drug)
• progesterone (biological)
• placebo-recFSH (follitropin alfa) (drug)
• placebo-corifollitropin alfa (drug)
• open-label recFSH (biological)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Org 36286 (drug) — also listed as: Corifollitropin alfa
• Lyndiol® (drug) — also listed as: 50 μg ethinylestradiol + 2.5 mg lynestrenol

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• MK-8962 (drug) — also listed as: Corifollitropin alfa
• recFSH (drug) — also listed as: follitropin beta
• Ganirelix (drug) — also listed as: Ganirelix acetate or Ganirelix diacetate
• human Chorionic Gonadotropin (hCG) (drug) — also listed as: human Chorionic Gonadotrophin
• Progesterone (drug) — also listed as: Crinone®

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.